Back to top

Analyst Blog

Zacks Equity Research

Multi-Million Deal for Accenture

ACN IBM

 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

It has been noted that orders are flowing regularly for the consulting and outsourcing company Accenture Plc. (ACN - Analyst Report). The company has regularly won orders; the recent addition is a deal from The Phoenix Partnership (“TPP”). Accenture is required to deploy patient administration system for the National Health Services (“NHS”) in southern England, across nine community health systems.

The multi-million dollar agreement will see the collaboration of Accenture and TPP to create a single electronic patient record system. This deployment will help clinicians to assess and exchange health information throughout the healthcare community.

Accenture will partner the Trusts in Southern Community & Child Health Procurement consortium for the implementation of the TPP SystmOne solution. Additionally, Accenture will provide support for integrating, hosting and deployment of the applications for the solution.

Moreover, Accenture will also assist TPP in adding up capabilities into the SystmOne platform such as e-prescribing, to support community services, community hospitals, minor injury management units and child health related issues.

Now the EHR is gaining ground across the globe and most of the healthcare companies and medical organizations have been adopting this new technology. Some of the government departments are taking the help of Electronic medical records, in order to rationalize health care costs, and help the doctors treat patients efficiently.

Also, an interim survey by the outsourcing and consulting services provider reveals that demand for Accenture’s services from some healthcare companies are increasing. We believe that the opportunity will prove beneficial for Accenture’s revenue growth.

Though this is encouraging, we believe similar product offerings from the likes of Dell Inc and International Business Machines Corp. (IBM - Analyst Report) are concerns.

Currently, Accenture has a Zacks #3 Rank (Hold).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%